| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $0.94 | $0.55 | $1.63 | $4.06 | $4.44 | $1.27 | $0.67 | $0.68 |
| EPS (Diluted) | $0.93 | $0.54 | $1.61 | $3.96 | $4.35 | $1.25 | $0.66 | $0.67 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.4B | $5.9B | $5.3B | $5.3B | $6.0B | $5.9B | $5.1B | $4.6B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.3B | $0.3B | $0.4B | $0.4B | $0.3B | $0.2B | $0.2B |
| Total Liabilities | $5.4B | $5.1B | $4.5B | $4.4B | $5.1B | $5.2B | $4.4B | $3.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.9B | $0.9B | $0.9B | $0.9B | $0.9B | $0.7B | $0.6B | $0.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.5B | $-0.6B | $-0.1B | $0.7B | $0.1B | $-0.8B | $-0.5B | $-0.3B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.4B | $0.6B | $-0.1B | $-0.7B | $-0.1B | $0.8B | $0.4B | $0.3B |